Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware… Read more
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.003x
Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million) by net assets (CN¥5.73 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Changzhou Zhongying Science & Technology Co. Ltd
SHE:300936
|
0.015x |
|
Yinchuan Xinhua Commercial Group Co Ltd
SHG:600785
|
0.170x |
|
BHG Group AB Series B
LSE:0SOM
|
0.061x |
|
Sonida Senior Living Inc
NYSE:SNDA
|
0.139x |
|
Beijing ConST Instruments Technology Inc
SHE:300445
|
0.040x |
|
Scimee Sci &Tech Co Ltd
SHE:300425
|
0.039x |
|
M. Dias Branco S.A. Indústria e Comércio de Alimentos
SA:MDIA3
|
0.064x |
|
SillaJen Inc
KQ:215600
|
-0.040x |
Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2024)
The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.02 Billion | CN¥-85.05 Million | -0.014x | -122.65% |
| 2023-12-31 | CN¥6.29 Billion | CN¥392.50 Million | 0.062x | -89.47% |
| 2022-12-31 | CN¥6.77 Billion | CN¥4.01 Billion | 0.593x | +49.86% |
| 2021-12-31 | CN¥2.85 Billion | CN¥1.13 Billion | 0.395x | +22.57% |
| 2020-12-31 | CN¥1.11 Billion | CN¥359.68 Million | 0.323x | +783.28% |
| 2019-12-31 | CN¥615.62 Million | CN¥22.49 Million | 0.037x | -59.67% |
| 2018-12-31 | CN¥592.59 Million | CN¥53.67 Million | 0.091x | -52.68% |
| 2017-12-31 | CN¥242.93 Million | CN¥46.50 Million | 0.191x | -43.07% |
| 2016-12-31 | CN¥175.08 Million | CN¥58.86 Million | 0.336x | -13.84% |
| 2015-12-31 | CN¥115.39 Million | CN¥45.02 Million | 0.390x | +17.45% |
| 2014-12-31 | CN¥49.59 Million | CN¥16.47 Million | 0.332x | -28.26% |
| 2013-12-31 | CN¥13.60 Million | CN¥6.30 Million | 0.463x | -36.17% |
| 2012-12-31 | CN¥1.42 Million | CN¥1.03 Million | 0.725x | +103.22% |
| 2011-12-31 | CN¥21.45K | CN¥-482.90K | -22.514x | -- |